|
Basic Characteristics of Mutations
|
|
Mutation Site
|
M133T |
|
Mutation Site Sentence
|
Six amino acid mutations were located in the 'a' determinant, including P120T, K122R, M133T, F134L, D144A and G145A. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
S |
|
Standardized Encoding Gene
|
S
|
|
Genotype/Subtype
|
C |
|
Viral Reference
|
DQ089802;DQ089801;DQ089800;DQ089799;DQ089798;DQ089797;DQ089796;DQ089795;DQ089794;DQ089793
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Occult HBV Infection
|
|
Immune
|
Y |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
- |
|
Treatment
|
- |
|
Location
|
- |
|
Literature Information
|
|
PMID
|
20031483
|
|
Title
|
Reactivation of hepatitis B virus infection with persistently negative HBsAg on three HBsAg assays in a lymphoma patient undergoing chemotherapy
|
|
Author
|
Cheung WI,Chan HL,Leung VK,Tse CH,Fung K,Lin SY,Wong A,Wong VW,Chau TN
|
|
Journal
|
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
|
|
Journal Info
|
2010 Feb;47(2):193-5
|
|
Abstract
|
In patients with occult hepatitis B virus (HBV) infection, acute exacerbation may occur when they become immunocompromised. Usually, these patients develop hepatitis B surface antigen (HBsAg) seroreversion during the flare. Here we report on a patient with occult HBV infection, who developed HBV exacerbation after chemotherapy for diffuse large B-cell lymphoma. The resurgence of HBV DNA preceded the elevation of liver enzymes for 20 weeks. Atypically, despite high viraemia, serological tests showed persistently negative HBsAg using three different sensitive HBsAg assays (i.e., Architect, Murex and AxSYM). On comparing the amino acid sequence of the index patient with the consensus sequence, five mutations were found at pre-S1, five at pre-S2 and twenty-three mutations at the S region. Six amino acid mutations were located in the 'a' determinant, including P120T, K122R, M133T, F134L, D144A and G145A. The mutants K122R, F134L and G145A in our patient have not been tested for their sensitivity to Architect and Murex assays by the previous investigators and might represent the escape mutants to these assays.
|
|
Sequence Data
|
-
|
|
|